FREESTYLE LIBRE 14 DAY
Device
Abbott Laboratories
Total Payments
$6.8M
Transactions
819
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2022 | $6.8M | 819 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $6.8M | 819 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Accuracy Study of an Interstitial Fluid Glucose Sensor | Abbott Laboratories | $2.1M | 0 |
| Abbott Sensor Based B-Ketone Monitoring System Characterization Study using Capillary and/or Venous Ketone Reference | Abbott Laboratories | $885,620 | 0 |
| HbA1c Variation Study (GDAC) | Abbott Laboratories | $859,637 | 0 |
| Abbott Sensor Based Lactate Monitoring System Characterization Study using Venous and/or Capillary Lactate Reference | Abbott Laboratories | $582,608 | 0 |
| Abbott Sensor Based Glucose Monitoring System Characterization Study using Venous and/or Caplillary Glucose Reference | Abbott Laboratories | $458,852 | 0 |
| Use of the FreeStyle Libre 2 Flash Glucose Monitoring System to Reduce Hyperglycemia in People with T2 Diabetes: Intervention Arm Extension Study | Abbott Laboratories | $404,171 | 0 |
| EVALUATION OF FLASH CONTINUOUS GLUCOSE MONITORING TO REDUCE HYPERGLYCEMIA IN PEOPLE WITH T2 DIABETES | Abbott Laboratories | $311,668 | 0 |
| Characterization study of the FreeStyle Libre Flash Glucose Monitoring System Using Capillary Glucose Reference | Abbott Laboratories | $232,722 | 0 |
| Abbott Sensor Based Glucose Monitoring System Characterization Study Using Venous and/or Capillary Glucose Reference | Abbott Laboratories | $160,944 | 0 |
| Pilot Study to observe smartphone meal logging and insulin administration methods and motivations of people with type 2 diabetes | Abbott Laboratories | $142,893 | 0 |
| Effect of Common Interferents on Continuous Glucose Monitoring Systems | Abbott Laboratories | $124,865 | 0 |
| Alcohol Study | Abbott Laboratories | $123,550 | 0 |
| Characterization Study using Capillary or Venous Reference | Abbott Laboratories | $98,294 | 0 |
| Abbott Sensor Based Monitoring System Multiple Analyte Characterization Study Using Venous and/or Capillary Reference | Abbott Laboratories | $66,372 | 0 |
| iCGM Study | Abbott Laboratories | $59,963 | 0 |
| Exogenous Ketone Drink Study-Adult | Abbott Laboratories | $47,571 | 0 |
| Evaluation of Flash Continuous Glucose Monitoring to Reduce Hyperglycemia in People With T2 Diabetes | Abbott Laboratories | $35,906 | 0 |
| HbA1c Variation Study | Abbott Laboratories | $18,864 | 0 |
| TELEMEDICINE CONTINUOUS REMOTE MONITORING OF ADULTS WITH UNCONTROLLED DIABETES MELLITUS | Abbott Laboratories | $18,844 | 0 |
| Characterization Study of the FreeStyle Libre Flash Glucose Monitoring System Using Capillary Glucose Reference | Abbott Laboratories | $15,211 | 0 |
Top Doctors Receiving Payments for FREESTYLE LIBRE 14 DAY
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Idaho Falls, ID | $6.8M | 819 |
Ad
Manufacturing Companies
- Abbott Laboratories $6.8M
Product Information
- Type Device
- Total Payments $6.8M
- Total Doctors 0
- Transactions 819
About FREESTYLE LIBRE 14 DAY
FREESTYLE LIBRE 14 DAY is a device associated with $6.8M in payments to 0 healthcare providers, recorded across 819 transactions in the CMS Open Payments database. The primary manufacturer is Abbott Laboratories.
Payment data is available from 2022 to 2022. In 2022, $6.8M was paid across 819 transactions to 0 doctors.
The most common payment nature for FREESTYLE LIBRE 14 DAY is "Unspecified" ($6.8M, 100.0% of total).
FREESTYLE LIBRE 14 DAY is associated with 20 research studies, including "Accuracy Study of an Interstitial Fluid Glucose Sensor" ($2.1M).